“The past two years have shown how important it is for innovative companies to develop vaccines and advance medical advances. Amidst the pandemic and our aging population, the spotlight is on the industry to really grow and innovate,” said Som Safe, Founder and CEO of Purpose Investments. “We launched this fund to give Canadians the opportunity to gain actively managed exposure to healthcare companies that are changing the world with cutting-edge medical and technological advancements.”
Next Edge Capital’s Eden Rahim, one of the world’s leading health care investment experts, will actively manage the fund, while Purpose will serve as the fund’s deputy advisor.
Rahim has an academic background in Molecular Genetics and vast experience in the management of Life Sciences and Biotechnology departments. Based on their education and industry experience, their active management will position the fund to take advantage of growth opportunities in the biotech and healthcare industries.
“With this fund, we will work to strategically identify key healthcare companies that are developing innovations that will profoundly improve people’s lives,” Rahim said. “The Objectives of the Healthcare Innovation Yield ETF is to provide investors with exposure to unique opportunities that may not be on their radar, so that they can reap the full rewards of high-growth areas in health and science.”
“Eden is one of the leading global experts in healthcare investing, and someone who understands the math as well as the science that supports portfolios. We consider such an experienced portfolio manager to maximize growth opportunities in the space. and provide investors with a strategy to generate attractive yields,” said Seif.
